Rethinking Clinical Trials Reform During the COVID-19 Pandemic.

Nabhan, Chadi; Choueiri, Toni K; Mato, Anthony R

Nabhan, Chadi; Choueiri, Toni K; Mato, Anthony R.

Nabhan C; Caris Life Sciences, Precision Oncology Alliance, Irving, Texas.
Choueiri TK; Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina, Columbia.
Mato AR; Dana-Farber Cancer Institute, Boston, Massachusetts.

JAMA Oncol ; 6(9): 1327-1329, 2020 Sep 01.

Article in English | MEDLINE | ID: covidwho-696333

Subject(s)

Coronavirus Infections/epidemiology; Neoplasms/epidemiology; Pandemics; Pneumonia, Viral/epidemiology; Betacoronavirus/pathogenicity; COVID-19; Clinical Trials as Topic; Coronavirus Infections/complications; Coronavirus Infections/virology; Humans; Medical Oncology/trends; Neoplasms/complications; Neoplasms/virology; Pneumonia, Viral/complications; Pneumonia, Viral/virology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Neoplasms Type of study: Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: JAMA Oncol Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google